These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21858152)

  • 1. The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
    Bonomelli C; Doores KJ; Dunlop DC; Thaney V; Dwek RA; Burton DR; Crispin M; Scanlan CN
    PLoS One; 2011; 6(8):e23521. PubMed ID: 21858152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.
    Doores KJ; Bonomelli C; Harvey DJ; Vasiljevic S; Dwek RA; Burton DR; Crispin M; Scanlan CN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13800-5. PubMed ID: 20643940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
    Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
    J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.
    Kong L; Wilson IA; Kwong PD
    Proteins; 2015 Mar; 83(3):590-6. PubMed ID: 25546301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein.
    Behrens AJ; Vasiljevic S; Pritchard LK; Harvey DJ; Andev RS; Krumm SA; Struwe WB; Cupo A; Kumar A; Zitzmann N; Seabright GE; Kramer HB; Spencer DI; Royle L; Lee JH; Klasse PJ; Burton DR; Wilson IA; Ward AB; Sanders RW; Moore JP; Doores KJ; Crispin M
    Cell Rep; 2016 Mar; 14(11):2695-706. PubMed ID: 26972002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoform analysis of recombinant and human immunodeficiency virus envelope protein gp120 via higher energy collisional dissociation and spectral-aligning strategy.
    Yang W; Shah P; Toghi Eshghi S; Yang S; Sun S; Ao M; Rubin A; Jackson JB; Zhang H
    Anal Chem; 2014 Jul; 86(14):6959-67. PubMed ID: 24941220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions.
    Wang S; Voronin Y; Zhao P; Ishihara M; Mehta N; Porterfield M; Chen Y; Bartley C; Hu G; Han D; Wells L; Tiemeyer M; Lu S
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins.
    Biller M; Bolmstedt A; Hemming A; Olofsson S
    J Virol Methods; 1998 Dec; 76(1-2):87-100. PubMed ID: 9923743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.
    Raska M; Takahashi K; Czernekova L; Zachova K; Hall S; Moldoveanu Z; Elliott MC; Wilson L; Brown R; Jancova D; Barnes S; Vrbkova J; Tomana M; Smith PD; Mestecky J; Renfrow MB; Novak J
    J Biol Chem; 2010 Jul; 285(27):20860-9. PubMed ID: 20439465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
    Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
    J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells.
    Zhu X; Borchers C; Bienstock RJ; Tomer KB
    Biochemistry; 2000 Sep; 39(37):11194-204. PubMed ID: 10985765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.
    van Montfort T; Eggink D; Boot M; Tuen M; Hioe CE; Berkhout B; Sanders RW
    J Immunol; 2011 Nov; 187(9):4676-85. PubMed ID: 21957147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.
    Pejchal R; Doores KJ; Walker LM; Khayat R; Huang PS; Wang SK; Stanfield RL; Julien JP; Ramos A; Crispin M; Depetris R; Katpally U; Marozsan A; Cupo A; Maloveste S; Liu Y; McBride R; Ito Y; Sanders RW; Ogohara C; Paulson JC; Feizi T; Scanlan CN; Wong CH; Moore JP; Olson WC; Ward AB; Poignard P; Schief WR; Burton DR; Wilson IA
    Science; 2011 Nov; 334(6059):1097-103. PubMed ID: 21998254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry.
    François KO; Balzarini J
    J Biol Chem; 2011 Dec; 286(50):42900-10. PubMed ID: 22006924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
    Pritchard LK; Spencer DI; Royle L; Bonomelli C; Seabright GE; Behrens AJ; Kulp DW; Menis S; Krumm SA; Dunlop DC; Crispin DJ; Bowden TA; Scanlan CN; Ward AB; Schief WR; Doores KJ; Crispin M
    Nat Commun; 2015 Jun; 6():7479. PubMed ID: 26105115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of N-Glycan Structures on the Surface of Mature Dengue 2 Virus Derived from Insect Cells.
    Lei Y; Yu H; Dong Y; Yang J; Ye W; Wang Y; Chen W; Jia Z; Xu Z; Li Z; Zhang F
    PLoS One; 2015; 10(7):e0132122. PubMed ID: 26208004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission.
    Mathys L; Balzarini J
    PLoS One; 2015; 10(6):e0130621. PubMed ID: 26121645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate.
    Stansell E; Panico M; Canis K; Pang PC; Bouché L; Binet D; O'Connor MJ; Chertova E; Bess J; Lifson JD; Haslam SM; Morris HR; Desrosiers RC; Dell A
    PLoS One; 2015; 10(4):e0124784. PubMed ID: 25915761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.